| abstract |
The present application relates to a pharmaceutical composition and method for treating human genitourinary diseases and bone metastases, the pharmaceutical composition comprising an effective amount of an alkali metal arsenate or alkaline earth metal salt and/or a pharmaceutically acceptable adjuvant Agent. According to the invention, the alkali metal arsenite is sodium metaarsenite (AsO2Na) or potassium meta arsenite (AsO2K). The effective amount of the alkali metal arsenate or alkaline earth metal salt is from 0.0001 to 1500 mg/kg, preferably from 1 to 1000 mg/kg, more preferably from 1 to 150 mg/kg, and most preferably from 50 to 100 mg. / kg body weight / day. The pharmaceutical compositions of the present invention are preferably administered orally, for example, as a pharmaceutically acceptable carrier, diluent or excipient lozenge, capsule, powder, and/or solution. |